CoChat
Sign Up
Cited by 390Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes

Monnier, Louis, Colette, Claude, Wojtusciszyn, Anne, Dejager, Sylvie, Renard, Eric, Molinari, Nicolas, Owens, David R.·2017·Diabetes Care
DOI 10.2337/dc16-1769
Open this paper in CoChat — free account

Abstract

OBJECTIVE: To define the threshold for excess glucose variability (GV), one of the main features of dysglycemia in diabetes. RESEARCH DESIGN AND METHODS: A total of 376 persons with diabetes investigated at the University Hospital of Montpellier (Montpellier, France) underwent continuous glucose monitoring. Participants with type 2 diabetes were divided into several groups—groups 1, 2a, 2b, and 3 (n = 82, 28, 65, and 79, respectively)—according to treatment: 1) diet and/or insulin sensitizers alone; 2) oral therapy including an insulinotropic agent, dipeptidyl peptidase 4 inhibitors (group 2a) or sulfonylureas (group 2b); or 3) insulin. Group 4 included 122 persons with type 1 diabetes. Percentage coefficient of variation for glucose (%CV = [(SD of glucose)/(mean glucose)] × 100) and frequencies of hypoglycemia (interstitial glucose <56 mg/dL [3.1 mmol/L]) were computed. RESULTS: Percentages of CV (median [interquartile range]; %) increased significantly (P < 0.0001) from group 1 (18.1 [15.2–23.9]) to group 4 (37.2 [31.0–42.3]). In group 1, the upper limit of %CV, which served as reference for defining excess GV, was 36%. Percentages of patients with %CVs above this threshold in groups 2a, 2b, 3, and 4 were 0, 12.3, 19.0, and 55.7%, respectively. Hypoglycemia was more frequent in group 2b (P < 0.01) and groups 3 and 4 (P < 0.0001) when subjects with a %CV >36% were compared with those with %CV ≤36%. CONCLUSIONS: A %CV of 36% appears to be a suitable threshold to distinguish between stable and unstable glycemia in diabetes because beyond this limit, the frequency of hypoglycemia is significantly increased, especially in insulin-treated subjects.

Overview

Integrity signals

Registry

Crossref · 10.2337/dc16-1769

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 40 references

Research works printed but not linked: 1

  1. Midyett, 2016, Assessment of glucose variability by professional flash glucose monitoring across therapy groups for type 2 diabetes, Diabetes, 65, A222

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Monnier, L., Colette, C., Wojtusciszyn, A., Dejager, S., Renard, E., Molinari, N., & Owens, D. R.
Affiliations
  • Université de Montpellier (FR)
  • Pitié-Salpêtrière Hospital (FR)
  • Department of Endocrinology, Diabetes, and Nutrition, Montpellier University Hospital, University of Montpellier, Montpellier, France
  • Swansea University (GB)
Corresponding author
Monnier, Louis
ORCID
Venue
Diabetes Care
Publisher
American Diabetes Association
Published
2016-12-30
Volume
40
Issue
7
Pages
832-838
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
DOI
10.2337/dc16-1769
OpenAlex
W2566952971
Cited by
390
References
40
Citations by year
2026: 25 · 2025: 41 · 2024: 45 · 2023: 39 · 2022: 48 · 2021: 53 · 2020: 44 · 2019: 44 · 2018: 33 · 2017: 17
FWCI
31.40
Type
journal article
Language
en
Open access
closed
Licence
www.diabetesjournals.org/content/license (vor, 173 d)
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
glycemic variability, type 2 diabetes, type 1 diabetes, coefficient of variation, hypoglycemia, continuous glucose monitoring, insulin therapy, DPP-4 inhibitors, sulfonylureas, insulin sensitizers, glycemic stability, threshold
MeSH terms
Aged, Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Middle Aged, Sulfonylurea Compounds, Treatment Outcome, Dipeptidyl-Peptidase IV Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review